This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Lazydays (NASDAQ:GORV – Get Free Report) is anticipated to announce its earnings...
Okta (NASDAQ:OKTA – Get Free Report) had its price objective boosted by investme...
O’Reilly Automotive (NASDAQ:ORLY – Get Free Report)‘s stock had its “buy” rating...
RAPT Therapeutics (NASDAQ:RAPT – Get Free Report)‘s stock had its “buy” rating r...
Old Dominion Freight Line (NASDAQ:ODFL – Get Free Report) had its price objectiv...
ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) was upgraded by investment an...
Methanex (NASDAQ:MEOH – Get Free Report) (TSE:MX) was downgraded by analysts at ...
Orchestra BioMed (NASDAQ:OBIO – Get Free Report)‘s stock had its “buy” rating re...
Immunome (NASDAQ:IMNM – Get Free Report)‘s stock had its “outperform” rating rei...
Merus (NASDAQ:MRUS – Get Free Report) had its target price lowered by analysts a...
Magnite (NASDAQ:MGNI – Get Free Report)‘s stock had its “buy” rating reaffirmed ...
iHeartMedia (NASDAQ:IHRT – Get Free Report) had its price target reduced by equi...
Inozyme Pharma (NASDAQ:INZY – Get Free Report)‘s stock had its “outperform” rati...
Investment analysts at D. Boral Capital initiated coverage on shares of Pulmonx ...
4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report) had its price target d...
Hoth Therapeutics (NASDAQ:HOTH – Get Free Report)‘s stock had its “buy” rating r...